惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

博客园 - 三生石上(FineUI控件)
J
Java Code Geeks
Apple Machine Learning Research
Apple Machine Learning Research
Jina AI
Jina AI
博客园_首页
C
Check Point Blog
小众软件
小众软件
博客园 - 叶小钗
Blog — PlanetScale
Blog — PlanetScale
Engineering at Meta
Engineering at Meta
美团技术团队
Martin Fowler
Martin Fowler
Vercel News
Vercel News
D
Docker
罗磊的独立博客
B
Blog RSS Feed
The Cloudflare Blog
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
酷 壳 – CoolShell
酷 壳 – CoolShell
博客园 - 聂微东
Last Week in AI
Last Week in AI
T
Tailwind CSS Blog
雷峰网
雷峰网
博客园 - Franky

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Pediatrix Medical Group, Inc. (MD) Q1 2026 Earnings Call ...
SA Transcripts · 2026-05-05 · via All Articles on Seeking Alpha

Q1: 2026-05-05 Earnings Summary

EPS of $0.44 beats by $0.06

 | 

Revenue of

$476.20M

(3.89% Y/Y)

beats by $10.37M

Pediatrix Medical Group, Inc. (MD) Q1 2026 Earnings Call May 5, 2026 9:00 AM EDT

Company Participants

Mary Ann Moore - Chief Administrative Officer, Executive VP, General Counsel & Secretary
Mark Ordan - CEO & Executive Chairman
Kasandra Rossi - Executive VP, Treasurer & CFO

Conference Call Participants

Matthew Mardula - William Blair & Company L.L.C., Research Division
Jack Slevin - Jefferies LLC, Research Division
Pito Chickering - Deutsche Bank AG, Research Division

Presentation

Operator

Hello, and thank you for standing by. At this time, I would like to welcome everyone to the Q1 2026 Pediatrix Medical Group Earnings Conference Call. [Operator Instructions]

I would now like to turn the conference over to Mary Ann Moore, General Counsel. You may begin.

Mary Ann Moore
Chief Administrative Officer, Executive VP, General Counsel & Secretary

Thank you, operator, and good morning. Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Litigation Reform Act of 1995 and -- these forward-looking statements are based on assumptions and assessments made by Pediatrix management in light of their experience and assessment of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements made during this call are made as of today, and Pediatrix undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the company's filings with the SEC, including the section entitled Risk Factors.

In today's remarks by management, we will be discussing non-GAAP financial metrics. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measures can be found in this morning's press